Paratek Pharmaceuticals

www.paratekpharma.com
75 Arlington St, Suite 500
Boston, MA 02116

Company Info

Phone
(617) 807-6600

Year Established
1996

Ticker
PRTK

Exchange
NASDAQ

Contacts

Evan Loh, M.D.
CEO

Adam Woodrow
President & CCO

Jonathan Light
Deputy General Counsel

Randy Brenner
CDO & CRO

Company Description

Paratek, formerly Transcept Pharma and Novacea, is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use.